vs
Side-by-side financial comparison of LANDSTAR SYSTEM INC (LSTR) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.2B, roughly 1.3× LANDSTAR SYSTEM INC). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs 3.4%, a 1.1% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 1.6%). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -2.2%).
Landstar System, Inc. is an American transportation services company specializing in logistics and, more specifically, third-party logistics. Landstar utilizes an extensive network of over 8,800 independent owner-operators, referred to internally as business capacity owners (BCOs), over 1,000 independent freight agents, and over 70,000 vetted carriers. Landstar provides services principally throughout the United States and to a lesser extent in Canada and between the U.S. and Canada, Mexico, ...
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
LSTR vs ONC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $1.5B |
| Net Profit | $39.4M | $66.5M |
| Gross Margin | 9.6% | 90.5% |
| Operating Margin | 4.5% | 12.4% |
| Net Margin | 3.4% | 4.4% |
| Revenue YoY | 1.6% | 32.8% |
| Net Profit YoY | 32.3% | 143.8% |
| EPS (diluted) | $1.16 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $1.5B | ||
| Q3 25 | $1.2B | $1.4B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.2B | $1.1B | ||
| Q4 24 | $1.2B | $1.1B | ||
| Q3 24 | $1.2B | $1.0B | ||
| Q2 24 | $1.2B | $929.2M |
| Q1 26 | $39.4M | — | ||
| Q4 25 | $23.9M | $66.5M | ||
| Q3 25 | $19.4M | $124.8M | ||
| Q2 25 | $41.9M | $94.3M | ||
| Q1 25 | $29.8M | $1.3M | ||
| Q4 24 | $46.2M | $-151.9M | ||
| Q3 24 | $50.0M | $-121.3M | ||
| Q2 24 | $52.6M | $-120.4M |
| Q1 26 | 9.6% | — | ||
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% |
| Q1 26 | 4.5% | — | ||
| Q4 25 | 2.5% | 12.4% | ||
| Q3 25 | 2.2% | 11.5% | ||
| Q2 25 | 4.6% | 6.7% | ||
| Q1 25 | 3.4% | 1.0% | ||
| Q4 24 | 4.8% | -7.0% | ||
| Q3 24 | 5.2% | -12.0% | ||
| Q2 24 | 5.6% | -11.5% |
| Q1 26 | 3.4% | — | ||
| Q4 25 | 2.0% | 4.4% | ||
| Q3 25 | 1.6% | 8.8% | ||
| Q2 25 | 3.5% | 7.2% | ||
| Q1 25 | 2.6% | 0.1% | ||
| Q4 24 | 3.8% | -13.5% | ||
| Q3 24 | 4.1% | -12.1% | ||
| Q2 24 | 4.3% | -13.0% |
| Q1 26 | $1.16 | — | ||
| Q4 25 | $0.70 | $0.05 | ||
| Q3 25 | $0.56 | $0.08 | ||
| Q2 25 | $1.20 | $0.06 | ||
| Q1 25 | $0.85 | $0.00 | ||
| Q4 24 | $1.30 | $-0.10 | ||
| Q3 24 | $1.41 | $-0.09 | ||
| Q2 24 | $1.48 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $411.0M | $4.5B |
| Total DebtLower is stronger | $26.1M | $836.4M |
| Stockholders' EquityBook value | $799.0M | $4.4B |
| Total Assets | $1.6B | $8.2B |
| Debt / EquityLower = less leverage | 0.03× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $411.0M | — | ||
| Q4 25 | $452.2M | $4.5B | ||
| Q3 25 | $434.4M | $4.0B | ||
| Q2 25 | $426.2M | $2.8B | ||
| Q1 25 | $473.4M | $2.5B | ||
| Q4 24 | $566.6M | $2.6B | ||
| Q3 24 | $531.3M | $2.7B | ||
| Q2 24 | $504.0M | $2.6B |
| Q1 26 | $26.1M | — | ||
| Q4 25 | $0 | $836.4M | ||
| Q3 25 | $0 | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | $0 | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — |
| Q1 26 | $799.0M | — | ||
| Q4 25 | $795.7M | $4.4B | ||
| Q3 25 | $888.7M | $4.1B | ||
| Q2 25 | $921.8M | $3.8B | ||
| Q1 25 | $930.8M | $3.5B | ||
| Q4 24 | $972.4M | $3.3B | ||
| Q3 24 | $1.0B | $3.4B | ||
| Q2 24 | $1.0B | $3.4B |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $8.2B | ||
| Q3 25 | $1.7B | $7.6B | ||
| Q2 25 | $1.7B | $6.3B | ||
| Q1 25 | $1.7B | $5.8B | ||
| Q4 24 | $1.8B | $5.9B | ||
| Q3 24 | $1.8B | $5.8B | ||
| Q2 24 | $1.8B | $5.7B |
| Q1 26 | 0.03× | — | ||
| Q4 25 | 0.00× | 0.19× | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $417.3M |
| Free Cash FlowOCF − Capex | — | $379.8M |
| FCF MarginFCF / Revenue | — | 25.4% |
| Capex IntensityCapex / Revenue | — | 2.5% |
| Cash ConversionOCF / Net Profit | — | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $72.7M | $417.3M | ||
| Q3 25 | $89.3M | $402.6M | ||
| Q2 25 | $7.1M | $263.6M | ||
| Q1 25 | $55.7M | $44.1M | ||
| Q4 24 | $61.1M | $75.2M | ||
| Q3 24 | $83.1M | $188.4M | ||
| Q2 24 | $48.1M | $-95.6M |
| Q1 26 | — | — | ||
| Q4 25 | $70.5M | $379.8M | ||
| Q3 25 | $86.0M | $354.5M | ||
| Q2 25 | $4.7M | $219.8M | ||
| Q1 25 | $53.8M | $-12.3M | ||
| Q4 24 | $54.4M | $-17.3M | ||
| Q3 24 | $75.6M | $54.7M | ||
| Q2 24 | $40.6M | $-205.5M |
| Q1 26 | — | — | ||
| Q4 25 | 6.0% | 25.4% | ||
| Q3 25 | 7.1% | 25.1% | ||
| Q2 25 | 0.4% | 16.7% | ||
| Q1 25 | 4.7% | -1.1% | ||
| Q4 24 | 4.5% | -1.5% | ||
| Q3 24 | 6.2% | 5.5% | ||
| Q2 24 | 3.3% | -22.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 2.5% | ||
| Q3 25 | 0.3% | 3.4% | ||
| Q2 25 | 0.2% | 3.3% | ||
| Q1 25 | 0.2% | 5.0% | ||
| Q4 24 | 0.6% | 8.2% | ||
| Q3 24 | 0.6% | 13.3% | ||
| Q2 24 | 0.6% | 11.8% |
| Q1 26 | — | — | ||
| Q4 25 | 3.04× | 6.28× | ||
| Q3 25 | 4.61× | 3.22× | ||
| Q2 25 | 0.17× | 2.79× | ||
| Q1 25 | 1.87× | 34.71× | ||
| Q4 24 | 1.32× | — | ||
| Q3 24 | 1.66× | — | ||
| Q2 24 | 0.91× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
